- By Kamal Kumar
- Tue, 01 Oct 2024 05:51 PM (IST)
- Source:JND
China Diabetes Cure: Young people with diabetes might have good news as Chinese scientists claimed to have achieved a breakthrough in completely curing the disease using a minimally invasive procedure. Chinese medical experts said that they cured a 25-year-old woman from Tianjin of chronic diabetes by using a stem cell transplant, a PTI report stated, quoting Shanghai-based The Paper news.
Surprisingly, the patient's body was able to regulate her blood sugar naturally within two and a half months from the surgery, a procedure which was minimally invasive and lasted for only half an hour. The study was published by the scientists in the peer-reviewed journal Cell last week.
The scientific study involved researchers from Tianjin First Central Hospital and Peking University, the report stated.
How Was The Woman Treated Of Diabetes
The Chinese researchers obtained regulatory permission for the study in June last year and subsequently carried out the transplant on the first patient, the report added.
The Cell research paper further stated that the study used ‘chemically induced pluripotent stem-cell-derived islets’ or CiPSC islets in the transplant.
The researchers first obtained adipose tissue from the patient and used chemical processes to convert them into pluripotent stem cells. These cells were then transformed into the islets cells and transplanted into the body of the patient and as the cells were obtained from the body of the patient, no cell rejection was noticed.
History of Patient
The patient was diseased by Type-1 diabetes for over 11 years and already had two liver transplants and one unsuccessful pancreatic islet cell transplant. She used to suffer serious episodes of blood sugar level fluctuations and severe hypoglycaemia.
According to the research, her blood sugar levels gradually normalised, and her need for insulin-based medication decreased after the successful stem cell transplant.
She no longer needed insulin injections 75 days after the transplant. Five months post-transplant, her blood sugar levels remained within the target range more than 98% of the time, and this stability has been maintained, according to the statement.